4//SEC Filing
Kalnik Matthew W. 4
Accession 0001455244-10-000118
CIK 0000072444other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 6:03 PM ET
Size
5.2 KB
Accession
0001455244-10-000118
Insider Transaction Report
Form 4
Kalnik Matthew W.
SVP Strategic Plan. & Bus. Ops
Transactions
- Sale
Common Stock
2010-07-19$5.48/sh−1,625$8,905→ 45,725.104 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001459477
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 6:03 PM ET
- Size
- 5.2 KB